USC.edu
Are You a Patient?

Kyle M. Hurth, MD, PhD

Associate Professor of Clinical Pathology

Program Director, Neuropathology Fellowship Program

Immunohistochemistry Laboratory Director

Image of Kyle M. Hurth, MD, PhD
Is this your profile? Click to edit
Phone +1 323 442 8592
Email [email protected]
CTSI Profile

Publications

  • Comparative study of neuroendocrine acquisition and biomarker expression between neuroendocrine and usual prostatic carcinoma. Prostate. 2021 06; 81(8):469-477.. View in PubMed
  • Clinical utility of comprehensive genomic profiling in central nervous system tumors of children and young adults. Neurooncol Adv. 2021 Jan-Dec; 3(1):vdab037.. View in PubMed
  • Phase I trial of intranasal NEO100, highly purified perillyl alcohol, in adult patients with recurrent glioblastoma. Neurooncol Adv. 2021 Jan-Dec; 3(1):vdab005.. View in PubMed
  • Chronic Aspiration Pneumonitis Caused by Spontaneous Cerebrospinal Fluid Fistulae of the Skull Base. Laryngoscope. 2021 03; 131(3):462-466.. View in PubMed
  • Hemorrhagic Presentation of Rathke Cleft Cysts: A Surgical Case Series. Oper Neurosurg. 2020 05 01; 18(5):470-479.. View in PubMed
  • Ultra-high field magnetic resonance imaging for localization of corticotropin-secreting pituitary adenomas. Neuroradiology. 2020 Aug; 62(8):1051-1054.. View in PubMed
  • What Genes Can Tell: A Closer Look at Vestibular Schwannoma. Otol Neurotol. 2020 04; 41(4):522-529.. View in PubMed
  • Fatal refractory cardiac arrest as presentation of systemic amyloidosis. Respir Med Case Rep. 2020; 30:101042.. View in PubMed
  • Surgical management of clinically silent thyrotropin pituitary adenomas: A single center series of 20 patients. J Clin Neurosci. 2020 Jan; 71:70-75.. View in PubMed
  • ZBTB16: A new biomarker for primitive neuroectodermal tumor element / Ewing sarcoma. Pathol Res Pract. 2019 Oct; 215(10):152536.. View in PubMed

Similar People